Two Big Mergers and Acquisitions in the 340B Service Industry Announced

Skip Devanny, the longtime RxStrategies CEO has been named CEO of the newly branded and larger company Pillr Health. Meanwhile, Nuvem CEO Scott Seidelmann touted his company's acquisition of 340B pharmacy analytics provider Louvir.
Several major 340B service companies announced mergers and acquisitions this week that officials said will expand their offerings and resources [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

South Dakota Introduces 340B Contract Pharmacy Access Bill; Hawaii Advances Legislation; and Three States Push 340B-PBM Bills

South Dakota is now the 12th state to introduce legislation to bar drugmaker 340B contract pharmacy restrictions in the 2025 legislative session.
South Dakota recently became the 12th state to introduce a 340B contract pharmacy access bill in 2025, and a Hawaii [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Connecticut Bill Would Make Medicaid Reimbursement Contingent on 340B Reporting Requirements

A bill introduced last week would require 340B covered entities in Connecticut to report how they use program savings or risk losing their Medicaid reimbursement .
A newly introduced Connecticut bill would require 340B covered entities to report how they use program savings as a condition [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Group Moves to Join Federal Case to Fight J&J’s Contested 340B Rebate Proposal

UMass Memorial Medical Center, along with 340B Health and one additional member hospital, filed a motion to intervene in a federal court case to argue against J&J's contested 340B rebate proposal.
A major hospital advocacy group and two of its members are seeking to intervene in a high-profile federal court case [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

HELP Committee Questions RFK Jr. on Drug Pricing, Medicare and Medicaid but Not 340B 

HHS Secretary nominee Robert F. Kennedy Jr. appeared before the the Senate Health, Education, Labor and Pensions Committee on Thursday.
Robert F. Kennedy Jr., President Donald Trump’s pick to lead the U.S. Department of Health and Human Services (HHS), fielded [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

‘Deceit and Lies’: State Providers Slam Dark Money Ad Targeting 340B Contract Pharmacy Access Bills

Provider groups slammed a new anti-340B ad from Building America's Future, a conservative nonprofit that does not disclose its donors.
State provider groups are forcefully pushing back against a new dark money ad campaign they say is spreading “shameful” misinformation [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Georgia is 11th State to Introduce 340B Contract Pharmacy Access Bill in 2025

Georgia state Rep. Todd Jones (R) introduced a bill prohibiting drugmaker 340B contract pharmacy restrictions in the state.
Georgia has become the 11th state to introduce a 340B contract pharmacy bill in the opening weeks of the 2025 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

RFK Jr. Backs PBM, Drug Pricing Reform at Senate Confirmation Hearing, 340B Not Discussed but Could Come Up Today

HHS Secretary nominee Robert F. Kennedy Jr. offered support for pharmacy benefit manager and prescription drug pricing reform, but did not comment specifically on the 340B program during his Senate Finance Committee confirmation hearing on Wednesday.
Robert F. Kennedy Jr., President Donald Trump’s (R) Health and Human Services (HHS) secretary nominee, offered support for pharmacy benefit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Trump Administration Signals Support for IRA Drug Price Negotiations

The Centers for Medicare and Medicaid Services signaled in a Wednesday statement that it will continue the Inflation Reduction Act’s Medicare Part D drug price negotiations.
The Trump Administration indicated Wednesday that it will continue the Inflation Reduction Act’s (IRA) Medicare drug price negotiations, a signature [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

White House Rescinds Funding Freeze, But Concern Among Health Centers Remain 

President Donald Trump (R) addressed the media Wednesday after rescinding a memo to freeze trillions of dollars of federal funds.
The White House this week issued and then quickly rescinded a policy that froze trillions in federal funding following multiple [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live